Copyright Reports & Markets. All rights reserved.

Global Cancer Pain Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Cancer Pain

      • 1.1 Definition of Cancer Pain
      • 1.2 Cancer Pain Segment by Type
        • 1.2.1 Global Cancer Pain Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Opioids
        • 1.2.3 Non-Steroidal Anti-Inflammatory Drugs
        • 1.2.4 Others
      • 1.3 Cancer Pain Segment by Applications
        • 1.3.1 Global Cancer Pain Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Paracetamol Treatment-Related Immunotherapy
        • 1.3.3 Radiotherapy
        • 1.3.4 Chemotherapy
        • 1.3.5 Hormone Therapy
      • 1.4 Global Cancer Pain Overall Market
        • 1.4.1 Global Cancer Pain Revenue (2014-2025)
        • 1.4.2 Global Cancer Pain Production (2014-2025)
        • 1.4.3 North America Cancer Pain Status and Prospect (2014-2025)
        • 1.4.4 Europe Cancer Pain Status and Prospect (2014-2025)
        • 1.4.5 China Cancer Pain Status and Prospect (2014-2025)
        • 1.4.6 Japan Cancer Pain Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Cancer Pain Status and Prospect (2014-2025)
        • 1.4.8 India Cancer Pain Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Cancer Pain
      • 2.3 Manufacturing Process Analysis of Cancer Pain
      • 2.4 Industry Chain Structure of Cancer Pain

      3 Development and Manufacturing Plants Analysis of Cancer Pain

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Cancer Pain Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Cancer Pain
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Cancer Pain Production and Capacity Analysis
      • 4.2 Cancer Pain Revenue Analysis
      • 4.3 Cancer Pain Price Analysis
      • 4.4 Market Concentration Degree

      5 Cancer Pain Regional Market Analysis

      • 5.1 Cancer Pain Production by Regions
        • 5.1.1 Global Cancer Pain Production by Regions
        • 5.1.2 Global Cancer Pain Revenue by Regions
      • 5.2 Cancer Pain Consumption by Regions
      • 5.3 North America Cancer Pain Market Analysis
        • 5.3.1 North America Cancer Pain Production
        • 5.3.2 North America Cancer Pain Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Cancer Pain Import and Export
      • 5.4 Europe Cancer Pain Market Analysis
        • 5.4.1 Europe Cancer Pain Production
        • 5.4.2 Europe Cancer Pain Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Cancer Pain Import and Export
      • 5.5 China Cancer Pain Market Analysis
        • 5.5.1 China Cancer Pain Production
        • 5.5.2 China Cancer Pain Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Cancer Pain Import and Export
      • 5.6 Japan Cancer Pain Market Analysis
        • 5.6.1 Japan Cancer Pain Production
        • 5.6.2 Japan Cancer Pain Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Cancer Pain Import and Export
      • 5.7 Southeast Asia Cancer Pain Market Analysis
        • 5.7.1 Southeast Asia Cancer Pain Production
        • 5.7.2 Southeast Asia Cancer Pain Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Cancer Pain Import and Export
      • 5.8 India Cancer Pain Market Analysis
        • 5.8.1 India Cancer Pain Production
        • 5.8.2 India Cancer Pain Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Cancer Pain Import and Export

      6 Cancer Pain Segment Market Analysis (by Type)

      • 6.1 Global Cancer Pain Production by Type
      • 6.2 Global Cancer Pain Revenue by Type
      • 6.3 Cancer Pain Price by Type

      7 Cancer Pain Segment Market Analysis (by Application)

      • 7.1 Global Cancer Pain Consumption by Application
      • 7.2 Global Cancer Pain Consumption Market Share by Application (2014-2019)

      8 Cancer Pain Major Manufacturers Analysis

      • 8.1 BioDelivery Science
        • 8.1.1 BioDelivery Science Cancer Pain Production Sites and Area Served
        • 8.1.2 BioDelivery Science Product Introduction, Application and Specification
        • 8.1.3 BioDelivery Science Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 ProStrakan Group
        • 8.2.1 ProStrakan Group Cancer Pain Production Sites and Area Served
        • 8.2.2 ProStrakan Group Product Introduction, Application and Specification
        • 8.2.3 ProStrakan Group Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Teva pharmaceuticals
        • 8.3.1 Teva pharmaceuticals Cancer Pain Production Sites and Area Served
        • 8.3.2 Teva pharmaceuticals Product Introduction, Application and Specification
        • 8.3.3 Teva pharmaceuticals Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Eli-Lilly
        • 8.4.1 Eli-Lilly Cancer Pain Production Sites and Area Served
        • 8.4.2 Eli-Lilly Product Introduction, Application and Specification
        • 8.4.3 Eli-Lilly Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Grunenthal Group
        • 8.5.1 Grunenthal Group Cancer Pain Production Sites and Area Served
        • 8.5.2 Grunenthal Group Product Introduction, Application and Specification
        • 8.5.3 Grunenthal Group Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 GW Pharmaceuticals
        • 8.6.1 GW Pharmaceuticals Cancer Pain Production Sites and Area Served
        • 8.6.2 GW Pharmaceuticals Product Introduction, Application and Specification
        • 8.6.3 GW Pharmaceuticals Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Johnson＆Johnson
        • 8.7.1 Johnson＆Johnson Cancer Pain Production Sites and Area Served
        • 8.7.2 Johnson＆Johnson Product Introduction, Application and Specification
        • 8.7.3 Johnson＆Johnson Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Meda Pharmaceuticals
        • 8.8.1 Meda Pharmaceuticals Cancer Pain Production Sites and Area Served
        • 8.8.2 Meda Pharmaceuticals Product Introduction, Application and Specification
        • 8.8.3 Meda Pharmaceuticals Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Orexo
        • 8.9.1 Orexo Cancer Pain Production Sites and Area Served
        • 8.9.2 Orexo Product Introduction, Application and Specification
        • 8.9.3 Orexo Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Sanofi
        • 8.10.1 Sanofi Cancer Pain Production Sites and Area Served
        • 8.10.2 Sanofi Product Introduction, Application and Specification
        • 8.10.3 Sanofi Cancer Pain Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 WEX Pharmaceuticals

      9 Development Trend of Analysis of Cancer Pain Market

      • 9.1 Global Cancer Pain Market Trend Analysis
        • 9.1.1 Global Cancer Pain Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Cancer Pain Regional Market Trend
        • 9.2.1 North America Cancer Pain Forecast 2019-2025
        • 9.2.2 Europe Cancer Pain Forecast 2019-2025
        • 9.2.3 China Cancer Pain Forecast 2019-2025
        • 9.2.4 Japan Cancer Pain Forecast 2019-2025
        • 9.2.5 Southeast Asia Cancer Pain Forecast 2019-2025
        • 9.2.6 India Cancer Pain Forecast 2019-2025
      • 9.3 Cancer Pain Market Trend (Product Type)
      • 9.4 Cancer Pain Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Cancer Pain Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.
        The report, states that opioids will continue to dominate as a breakthrough cancer pain treatment, mostly due to available generics and physician familiarity.

        The global Cancer Pain market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Cancer Pain volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Pain market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Pain in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Cancer Pain manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        BioDelivery Science
        ProStrakan Group
        Teva pharmaceuticals
        Eli-Lilly
        Grunenthal Group
        GW Pharmaceuticals
        Johnson＆Johnson
        Meda Pharmaceuticals
        Orexo
        Sanofi
        WEX Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Opioids
        Non-Steroidal Anti-Inflammatory Drugs
        Others

        Segment by Application
        Paracetamol Treatment-Related Immunotherapy
        Radiotherapy
        Chemotherapy
        Hormone Therapy

        Buy now